Asia-pacific Epilepsy Devices Market Forecast 2022-2030
Description
Asia-pacific Epilepsy Devices Market Forecast 2022-2030
KEY FINDINGS
The Asia-Pacific epilepsy devices market is set to record an 8.05% CAGR during the forecast period, 2022-2030. Attractive training and research opportunities provided by key market players, the high prevalence of epilepsy, and the rising presence of the geriatric population in the region propel market growth.
MARKET INSIGHTS
The Asia-Pacific epilepsy devices market growth evaluation covers a detailed study of South Korea, China, Singapore, Taiwan, India, Indonesia, Japan, Australia & New Zealand, and Rest of Asia-Pacific. According to our study, there has been a rising prevalence of epilepsy in South Korea. The population’s aging is the primary cause of this rapid surge. In addition, South Korea also witnessed an increase in cases of epilepsy among elderly persons. Also, thousands of epilepsy incidences in the first year of life and early childhood also drive the demand for epilepsy devices in the country.
On the other hand, despite contemporary antiepileptic medicines (AEDs), up to 30-40% of epilepsy patients in Indonesia still experience seizures, and almost half of these could benefit from surgery. As a result, wearable and implantable gadgets will become more popular in the area during the predicted period. The greatest imaging technique available nationwide for patients with partial epilepsy is magnetic resonance imaging (MRI). While many clinics are still in the planning stage, some programs offer exceptional care for people with epilepsy.
In Singapore, recent developments in neuroimaging have drawn interest due to their potential to both improve our understanding of epileptogenic lesions and reveal new information about the pathophysiology of epilepsy. The study market in Singapore will continue to grow due to the rising number of clinical and experimental applications of machine learning and network analysis in epilepsy. The nation also has the greatest percentage of epilepsy surgical use, which raises the demand for epilepsy gadgets.
COMPETITIVE INSIGHTS
Some of the key players in the market are Koninklijke Philips NV, Nihon Kohden Corporation, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
KEY FINDINGS
The Asia-Pacific epilepsy devices market is set to record an 8.05% CAGR during the forecast period, 2022-2030. Attractive training and research opportunities provided by key market players, the high prevalence of epilepsy, and the rising presence of the geriatric population in the region propel market growth.
MARKET INSIGHTS
The Asia-Pacific epilepsy devices market growth evaluation covers a detailed study of South Korea, China, Singapore, Taiwan, India, Indonesia, Japan, Australia & New Zealand, and Rest of Asia-Pacific. According to our study, there has been a rising prevalence of epilepsy in South Korea. The population’s aging is the primary cause of this rapid surge. In addition, South Korea also witnessed an increase in cases of epilepsy among elderly persons. Also, thousands of epilepsy incidences in the first year of life and early childhood also drive the demand for epilepsy devices in the country.
On the other hand, despite contemporary antiepileptic medicines (AEDs), up to 30-40% of epilepsy patients in Indonesia still experience seizures, and almost half of these could benefit from surgery. As a result, wearable and implantable gadgets will become more popular in the area during the predicted period. The greatest imaging technique available nationwide for patients with partial epilepsy is magnetic resonance imaging (MRI). While many clinics are still in the planning stage, some programs offer exceptional care for people with epilepsy.
In Singapore, recent developments in neuroimaging have drawn interest due to their potential to both improve our understanding of epileptogenic lesions and reveal new information about the pathophysiology of epilepsy. The study market in Singapore will continue to grow due to the rising number of clinical and experimental applications of machine learning and network analysis in epilepsy. The nation also has the greatest percentage of epilepsy surgical use, which raises the demand for epilepsy gadgets.
COMPETITIVE INSIGHTS
Some of the key players in the market are Koninklijke Philips NV, Nihon Kohden Corporation, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
162 Pages
- 1. Research Scope & Methodology
- 1.1. Study Objectives
- 1.2. Scope Of Study
- 1.3. Methodology
- 1.4. Assumptions & Limitations
- 2. Executive Summary
- 2.1. Market Size & Estimates
- 2.2. Market Overview
- 3. Market Dynamics
- 3.1. Key Drivers
- 3.1.1. Soaring Occurrences Of Epilepsy Globally
- 3.1.2. Onset Of Epilepsy In Elderly People
- 3.1.3. Mitigation Of Epilepsy Using Early Diagnosis
- 3.1.4. Surge In Post-traumatic Epilepsy With Rising Brain Injury Cases
- 3.2. Key Restraints
- 3.2.1. Misperceptions And Misinformation About Epilepsy
- 3.2.2. Shortage Of Neurology Specialists In The Healthcare System
- 4. Key Analytics
- 4.1. Impact Of Covid-19 On Epilepsy Devices Market
- 4.2. Key Market Trends
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Buyers Power
- 4.3.2. Suppliers Power
- 4.3.3. Substitution
- 4.3.4. New Entrants
- 4.3.5. Industry Rivalry
- 4.4. Opportunity Matrix
- 4.5. Vendor Landscape
- 4.6. Value Chain Analysis
- 4.7. Key Buying Criteria
- 4.7.1. Comfort & Usability
- 4.7.2. Product Features
- 4.7.3. Confidentiality
- 4.8. Regulatory Framework
- 5. Market By Product Type
- 5.1. Conventional Devices
- 5.2. Wearable Devices
- 5.2.1. Watches
- 5.2.2. Bracelets
- 5.2.3. Camera Devices
- 5.2.4. Mattress Devices
- 5.2.5. Anti-suffocation Pillows
- 5.2.6. Other Wearable Devices
- 5.3. Implantable Devices
- 6. Market By Technology
- 6.1. Vagus Nerve Stimulation
- 6.2. Deep Brain Stimulation
- 6.2.1. Movement Disorders
- 6.2.2. Epilepsy
- 6.3. Accelerometry
- 6.4. Responsive Neurostimulation
- 7. Market By Detection & Prediction Devices Type
- 7.1. Electroencephalogram
- 7.2. Intracranial Eeg
- 7.3. Surface Electromyography
- 7.4. Electrocardiography
- 7.5. Video Detection Systems
- 7.6. Electrodermal Activity
- 7.7. Implanted Advisory Systems
- 7.8. Other Detection & Prediction Device Types
- 8. Market By End-user
- 8.1. Hospitals & Clinics
- 8.2. Neurology Centers
- 8.3. Home Care Settings
- 8.4. Other End-users
- 9. Geographical Analysis
- 9.1. Asia-pacific
- 9.1.1. Market Estimates & Sizes
- 9.1.2. Key Growth Enablers
- 9.1.3. Key Challenges
- 9.1.4. Key Players
- 9.1.5. Country Analysis
- 9.1.5.1. China
- 9.1.5.2. Japan
- 9.1.5.3. India
- 9.1.5.4. South Korea
- 9.1.5.5. Indonesia
- 9.1.5.6. Singapore
- 9.1.5.7. Taiwan
- 9.1.5.8. Australia & New Zealand
- 9.1.5.9. Rest Of Asia-pacific
- 10. Competitive Landscape
- 10.1. Key Strategic Developments
- 10.1.1. Acquisitions
- 10.1.2. Product Launches & Developments
- 10.1.3. Partnerships
- 10.2. Company Profiles
- 10.2.1. Boston Scientific Corporation
- 10.2.2. Cadwell Industries Inc
- 10.2.3. Compumedics Limited
- 10.2.4. Drägerwerk Ag & Co Kgaa
- 10.2.5. Empatica Inc
- 10.2.6. Koninklijke Philips Nv
- 10.2.7. Livanova Plc
- 10.2.8. Medtronic Plc
- 10.2.9. Natus Medical Incorporated
- 10.2.10. Neuropace Inc
- 10.2.11. Neurosoft
- 10.2.12. Nihon Kohden Corporation
- 10.2.13. Shenzhen Mindray Bio-medical Electronics Co Ltd
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
